Stock Track | Evolent Health Surges 9.50% Pre-market on Strong Q3 Results and Bullish 2026 Outlook

Stock Track

Nov 07, 2025

Evolent Health (EVH) shares soared 9.50% in pre-market trading on Friday, building on the previous day's 10.33% gain. The healthcare solutions provider continues to ride the wave of enthusiasm following its better-than-expected third-quarter results and a series of positive developments announced on Thursday.

The company reported Q3 revenue of $479.53 million, surpassing analyst expectations of $467.50 million. Evolent also revealed over $500 million in new annualized revenue for 2026 from two new agreements, contributing to a total of thirteen new contracts signed this year. This significant boost to future revenue streams has clearly excited investors.

Adding to the optimism, Evolent provided a strong outlook for both the near and long term. The company projects full-year 2025 revenue to reach $1.87 billion to $1.88 billion, with an impressive preliminary 2026 revenue forecast of $2.5 billion. This robust growth potential, coupled with innovative partnerships like the one announced with American Oncology Network aimed at streamlining cancer care, has fueled investor confidence in Evolent Health's future prospects.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1138489672"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1138489672\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1138489672?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-11-07 20:48","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1138489672","market":"hk","top_or_hot":-1,"title":"Stock Track | Evolent Health Surges 9.50% Pre-market on Strong Q3 Results and Bullish 2026 Outlook","media":"Stock Track","content":"<p>Evolent Health (EVH) shares soared 9.50% in pre-market trading on Friday, building on the previous day's 10.33% gain. The healthcare solutions provider continues to ride the wave of enthusiasm following its better-than-expected third-quarter results and a series of positive developments announced on Thursday.</p>\n\n<p>The company reported Q3 revenue of $479.53 million, surpassing analyst expectations of $467.50 million. Evolent also revealed over $500 million in new annualized revenue for 2026 from two new agreements, contributing to a total of thirteen new contracts signed this year. This significant boost to future revenue streams has clearly excited investors.</p>\n\n<p>Adding to the optimism, Evolent provided a strong outlook for both the near and long term. The company projects full-year 2025 revenue to reach $1.87 billion to $1.88 billion, with an impressive preliminary 2026 revenue forecast of $2.5 billion. This robust growth potential, coupled with innovative partnerships like the one announced with American Oncology Network aimed at streamlining cancer care, has fueled investor confidence in Evolent Health's future prospects.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Evolent Health Surges 9.50% Pre-market on Strong Q3 Results and Bullish 2026 Outlook</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Evolent Health Surges 9.50% Pre-market on Strong Q3 Results and Bullish 2026 Outlook\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2025-11-07 20:48</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Evolent Health (EVH) shares soared 9.50% in pre-market trading on Friday, building on the previous day's 10.33% gain. The healthcare solutions provider continues to ride the wave of enthusiasm following its better-than-expected third-quarter results and a series of positive developments announced on Thursday.</p>\n\n<p>The company reported Q3 revenue of $479.53 million, surpassing analyst expectations of $467.50 million. Evolent also revealed over $500 million in new annualized revenue for 2026 from two new agreements, contributing to a total of thirteen new contracts signed this year. This significant boost to future revenue streams has clearly excited investors.</p>\n\n<p>Adding to the optimism, Evolent provided a strong outlook for both the near and long term. The company projects full-year 2025 revenue to reach $1.87 billion to $1.88 billion, with an impressive preliminary 2026 revenue forecast of $2.5 billion. This robust growth potential, coupled with innovative partnerships like the one announced with American Oncology Network aimed at streamlining cancer care, has fueled investor confidence in Evolent Health's future prospects.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"EVH","symbol_name":"Evolent Health Inc","start_time":0,"source_url":"","article_id":"1138489672","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1138489672","pubTimestamp":1762519700,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Evolent Health (EVH) shares soared 9.50% in pre-market trading on Friday, building on the previous day's 10.33% gain. The healthcare solutions provider continues to ride the wave of enthusiasm...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"EVH":"Evolent Health Inc"},"translate_title":"股票追踪|Evolent Health盘前大涨9.50%，第三季度业绩强劲，2026年前景看涨","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"EVH":1},"content_text":"Evolent Health (EVH) shares soared 9.50% in pre-market trading on Friday, building on the previous day's 10.33% gain. The healthcare solutions provider continues to ride the wave of enthusiasm following its better-than-expected third-quarter results and a series of positive developments announced on Thursday.\nThe company reported Q3 revenue of $479.53 million, surpassing analyst expectations of $467.50 million. Evolent also revealed over $500 million in new annualized revenue for 2026 from two new agreements, contributing to a total of thirteen new contracts signed this year. This significant boost to future revenue streams has clearly excited investors.\nAdding to the optimism, Evolent provided a strong outlook for both the near and long term. The company projects full-year 2025 revenue to reach $1.87 billion to $1.88 billion, with an impressive preliminary 2026 revenue forecast of $2.5 billion. This robust growth potential, coupled with innovative partnerships like the one announced with American Oncology Network aimed at streamlining cancer care, has fueled investor confidence in Evolent Health's future prospects.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"2","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}